A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States

BACKGROUND Palliative care (PC) has been shown to be beneficial in end stage liver disease (ESLD), yet the hospitalization data for PC utilization is unknown. AIM To identify the trend of PC utilization for the special population of alcohol-associated ESLD patients, factors affecting its use and ascertain its impact on healthcare utilization. METHODS We analyzed around 78 million discharges from the 2007-2014 national inpatient sample and 2010-2014 national readmission database including adult patients admitted for decompensated alcohol-associated cirrhosis. We identified patients with PC consultation as a secondary diagnosis. Odds ratios (OR) and means were adjusted for confounders using multivariate regression analysis models. RESULTS Out of the total 1421849 hospitalizations for decompensated liver cirrhosis, 62782 (4.4%) hospitalizations had a PC consult, which increased from 0.8% (1258) of all alcohol-associated ESLD hospitalizations in 2007 to 6.6% in 2014 (P < 0.01). Patient and hospital characteristics associated with increased odds of PC utilization were advanced age, lower income, Medicaid coverage, teaching institution, urban location, length of stay > 3 d, prolonged ventilation, and administration of total parenteral nutrition (all P < 0.01). Palliative encounters in alcohol-associated ESLD and acute-on-chronic liver failure (ACLF) score were associated with increased odds of discharge to a rehabilitation facility, but significantly lower odds of 30-d readmissions (aOR: 0.35, 95%CI: 0.31-0.41), lower total hospitalization charges and lower mean hospitalization days (all P < 0.01). CONCLUSION Inpatient PC is sparingly used for patients with decompensated alcohol related liver disease, however it has increased over the past decade. PC consultation is associated with lower 30-d readmission rates on multivariate analysis, and lower hospitalization cost and length of stay in patients with ACLF score ≥ 2.

[1]  H. Goyal,et al.  Weekend admissions with ascites are associated with delayed paracentesis: A nationwide analysis of the 'weekend effect'. , 2020, Annals of hepatology.

[2]  Manish Kumar,et al.  Readmissions Rates After Myocardial Infarction for Gastrointestinal Bleeding: A National Perspective , 2020, Digestive Diseases and Sciences.

[3]  Y. Ho,et al.  Comparing Eight Prognostic Scores in Predicting Mortality of Patients with Acute-On-Chronic Liver Failure Who Were Admitted to an ICU: A Single-Center Experience , 2020, Journal of Clinical Medicine.

[4]  R. Woodman,et al.  Early palliative care referral in patients with end stage liver disease is associated with reduced resource utilisation. , 2019, Journal of gastroenterology and hepatology.

[5]  G. Garas,et al.  Long-term Liver-related Outcomes of Patients with Chronic Liver Diseases in Australia. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  P. Kwo,et al.  Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease. , 2020, Journal of palliative medicine.

[7]  J. Temel,et al.  Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  E. Kelly,et al.  Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  L. Celi,et al.  Palliative medicine and hospital readmissions in end-stage liver disease. , 2019, BMJ supportive & palliative care.

[10]  M. Rubens,et al.  Palliative Care Consultation Trends Among Hospitalized Patients With Advanced Cancer in the United States, 2005 to 2014 , 2018, The American journal of hospice & palliative care.

[11]  R. Fontana,et al.  The high burden of alcoholic cirrhosis in privately insured persons in the United States , 2018, Hepatology.

[12]  D. Donovan,et al.  Recent trends in liver transplantation for alcoholic liver disease in the United States , 2017, World journal of hepatology.

[13]  L. Celi,et al.  Palliative care access for hospitalized patients with end‐stage liver disease across the United States , 2017, Hepatology.

[14]  G. Rücker,et al.  Early palliative care for adults with advanced cancer. , 2017, The Cochrane database of systematic reviews.

[15]  T. Campbell,et al.  The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review. , 2017, Annals of hepatology.

[16]  J. Verne,et al.  Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention , 2016, Frontline Gastroenterology.

[17]  Alexander K. Smith,et al.  Underutilization of palliative care services in the liver transplant population , 2016, World journal of transplantation.

[18]  V. Navarro,et al.  Benefit of Early Palliative Care Intervention in End-Stage Liver Disease Patients Awaiting Liver Transplantation. , 2015, Journal of pain and symptom management.

[19]  R. Morrison,et al.  Palliative Care for the Seriously Ill. , 2015, The New England journal of medicine.

[20]  M. Buss,et al.  Integration of palliative care in end-stage liver disease and liver transplantation. , 2014, Journal of palliative medicine.

[21]  Christopher A. Clark,et al.  Use of Administrative Claims Data for Identifying Patients with Cirrhosis , 2013, Journal of clinical gastroenterology.

[22]  K. Eagar,et al.  Referral patterns and proximity to palliative care inpatient services by level of socio-economic disadvantage. A national study using spatial analysis , 2012, BMC Health Services Research.

[23]  T. Seufferlein,et al.  Prognostic indicators of survival in patients with compensated and decompensated cirrhosis , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[24]  Y. Kuo,et al.  Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis from the UNOS database , 2012, Hepatology.

[25]  M. A. Pérez-San-Gregorio,et al.  Quality of life in patients with kidney, liver or heart failure during the waiting list period. , 2006, Transplantation proceedings.

[26]  G. Guyatt,et al.  Health-related quality of life in chronic liver disease: the impact of type and severity of disease , 2001, American Journal of Gastroenterology.